Full Text View
Tabular View
No Study Results Posted
Related Studies
Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
This study has been completed.
Study NCT00378196   Information provided by Johns Hopkins University
First Received: September 18, 2006   Last Updated: October 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Telangiectasia
Additional conditions recognized in this trial
Telangiectasis
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Ranibizumab
Sponsors listed in this trial
Johns Hopkins University
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services